Ask AI

Genitourinary Cancers

Share

Program Content

Activities

  • ARCHES 5 Year OS
    ARCHES: Post Hoc Analysis of 5-Yr OS Outcomes for Phase III Trial of Enzalutamide + ADT vs Placebo + ADT in Patients With mHSPC
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 01, 2025

    Expires: November 30, 2025

  • EV 302 Responder Analysis
    EV-302/KEYNOTE-A39: Exploratory Analysis of Responders to Enfortumab Vedotin + Pembrolizumab vs Chemotherapy for Previously Untreated Advanced or Metastatic Urothelial Carcinoma
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 05, 2025

    Expires: December 04, 2025

  • Metacure B2 Cohorts
    Metacure (B2 Cohorts): Phase II Trial of Intensified Hormonal Blockade With SBRT in Oligometastatic Castration-Sensitive Prostate Cancer
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 09, 2025

    Expires: December 08, 2025

  • NIAGARA
    NIAGARA: Exploratory ctDNA Analysis in Patients With MIBC Who Received Neoadjuvant Chemotherapy With or Without Durvalumab
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 10, 2025

    Expires: December 09, 2025

  • JAVELIN Bladder Medley
    Phase II JAVELIN Bladder Medley: Interim Analysis of 1L Maintenance Therapy With Avelumab + Sacituzumab Govitecan vs Avelumab for Advanced Urothelial Carcinoma
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 10, 2025

    Expires: December 09, 2025

Supporters

Supported by an educational grant from Astellas.

Astellas